BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29672841)

  • 1. Mutant MYO1F alters the mitochondrial network and induces tumor proliferation in thyroid cancer.
    Diquigiovanni C; Bergamini C; Evangelisti C; Isidori F; Vettori A; Tiso N; Argenton F; Costanzini A; Iommarini L; Anbunathan H; Pagotto U; Repaci A; Babbi G; Casadio R; Lenaz G; Rhoden KJ; Porcelli AM; Fato R; Bowcock A; Seri M; Romeo G; Bonora E
    Int J Cancer; 2018 Oct; 143(7):1706-1719. PubMed ID: 29672841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.
    Ye F; Gao H; Xiao L; Zuo Z; Liu Y; Zhao Q; Chen H; Feng W; Fu B; Sun L; Jiang X; He D; Jiang H; Yang M; Li L; Chen F; Liu X; Li S; Li Z; Jiang Y; Cheng L; Bu H
    Int J Cancer; 2019 Mar; 144(6):1321-1330. PubMed ID: 30132833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2.
    Canzian F; Amati P; Harach HR; Kraimps JL; Lesueur F; Barbier J; Levillain P; Romeo G; Bonneau D
    Am J Hum Genet; 1998 Dec; 63(6):1743-8. PubMed ID: 9837827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer.
    McKay JD; Thompson D; Lesueur F; Stankov K; Pastore A; Watfah C; Strolz S; Riccabona G; Moncayo R; Romeo G; Goldgar DE
    J Med Genet; 2004 Jun; 41(6):407-12. PubMed ID: 15173224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomas.
    Bonora E; Evangelisti C; Bonichon F; Tallini G; Romeo G
    Br J Cancer; 2006 Dec; 95(11):1529-36. PubMed ID: 17088905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of
    Marques IJ; Gomes I; Pojo M; Pires C; Moura MM; Cabrera R; Santos C; van IJcken WFJ; Teixeira MR; Ramalho JS; Leite V; Cavaco BM
    Thyroid; 2021 Sep; 31(9):1366-1375. PubMed ID: 33906393
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers.
    Cirello V; Colombo C; Karapanou O; Pogliaghi G; Persani L; Fugazzola L
    Front Endocrinol (Lausanne); 2020; 11():589340. PubMed ID: 33488516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetrance of a rare familial mutation predisposing to papillary thyroid cancer.
    Saporito D; Brock P; Hampel H; Sipos J; Fernandez S; Liyanarachchi S; de la Chapelle A; Nagy R
    Fam Cancer; 2018 Jul; 17(3):431-434. PubMed ID: 29027612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC).
    Pereira JS; da Silva JG; Tomaz RA; Pinto AE; Bugalho MJ; Leite V; Cavaco BM
    Endocrine; 2015 May; 49(1):204-14. PubMed ID: 25381600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Rare Variants Predisposing to Thyroid Cancer.
    Wang Y; Liyanarachchi S; Miller KE; Nieminen TT; Comiskey DF; Li W; Brock P; Symer DE; Akagi K; DeLap KE; He H; Koboldt DC; de la Chapelle A
    Thyroid; 2019 Jul; 29(7):946-955. PubMed ID: 30957677
    [No Abstract]   [Full Text] [Related]  

  • 11. Germ-line mutations in
    Zhao Y; Yu T; Sun J; Wang F; Cheng C; He S; Chen L; Xie D; Fu L; Guan X; Yan A; Li Y; Miao G; Zhu X
    Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34326253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HABP2 Gene Mutations Do Not Cause Familial or Sporadic Non-Medullary Thyroid Cancer in a Highly Inbred Middle Eastern Population.
    Alzahrani AS; Murugan AK; Qasem E; Al-Hindi H
    Thyroid; 2016 May; 26(5):667-71. PubMed ID: 26906432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of a gene predisposing to familial thyroid tumors with cell oxyphilia to chromosome 19 and exclusion of JUN B as a candidate gene.
    Kraimps JL; Canzian F; Jost C; Menet E; Amati P; Levillian P; Harach R; Lesueur F; Barbier J; Romeo G; Bonneau D
    Surgery; 1999 Dec; 126(6):1188-94. PubMed ID: 10598206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BROX haploinsufficiency in familial nonmedullary thyroid cancer.
    Pasquali D; Torella A; Accardo G; Esposito D; Del Vecchio Blanco F; Salvatore D; Sabatino P; Pacini F; Barbato F; Castagna MG; Cantara S; Nigro V
    J Endocrinol Invest; 2021 Jan; 44(1):165-171. PubMed ID: 32385852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations.
    Cavaco BM; Batista PF; Martins C; Banito A; do Rosário F; Limbert E; Sobrinho LG; Leite V
    Endocr Relat Cancer; 2008 Mar; 15(1):207-15. PubMed ID: 18310288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of susceptibility gene mutations associated with the pathogenesis of familial nonmedullary thyroid cancer.
    Zhu J; Wu K; Lin Z; Bai S; Wu J; Li P; Xue H; Du J; Shen B; Wang H; Liu Y
    Mol Genet Genomic Med; 2019 Dec; 7(12):e1015. PubMed ID: 31642198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma.
    Prazeres HJ; Rodrigues F; Soares P; Naidenov P; Figueiredo P; Campos B; Lacerda M; Martins TC
    Fam Cancer; 2008; 7(2):141-9. PubMed ID: 17823852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MYO1F, unconventional myosin type 1F, gene is fused to MLL in infant acute monocytic leukemia with a complex translocation involving chromosomes 7, 11, 19 and 22.
    Taki T; Akiyama M; Saito S; Ono R; Taniwaki M; Kato Y; Yuza Y; Eto Y; Hayashi Y
    Oncogene; 2005 Aug; 24(33):5191-7. PubMed ID: 15897884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma.
    Bonora E; Rizzato C; Diquigiovanni C; Oudot-Mellakh T; Campa D; Vargiolu M; Guedj M; ; McKay JD; Romeo G; Canzian F; Lesueur F
    Int J Cancer; 2014 May; 134(9):2098-107. PubMed ID: 24127282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Familial Nonmedullary Thyroid Cancer A More Aggressive Type of Thyroid Cancer?
    Muallem Kalmovich L; Jabarin B; Koren S; Or K; Marcus E; Tkacheva I; Benbassat C; Steinschneider M
    Laryngoscope; 2021 Feb; 131(2):E677-E681. PubMed ID: 32761812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.